Clinical Trial Update: Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining endothelial dysfunction and subclinical atheromatosis in chronic hepatitis C infection and the effect of direct-acting a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hepatitis C

Snippet

Sponsor: Instituto de Investigación Marqués de Valdecilla | Conditions: Hepatitis C, Cardiovascular Diseases | Phase 4 | Status: UNKNOWN